Our blood health tests provide insight into your body’s vital functions, including cholesterol, sugar, and organ performance. These tests help detect early signs of conditions like anaemia, diabetes, and liver issues. Regular testing at Bids Chemist supports overall wellness and helps you take control of your health before problems arise.
This test measures how effectively your blood responds to activated protein C, a natural anticoagulant that helps prevent excessive clot formation. Abnormal results can indicate a genetic predisposition to clotting disorders, increasing the risk of conditions such as deep vein thrombosis, pulmonary embolism, or recurrent miscarriages. Blood is collected, and results are interpreted alongside other coagulation studies and clinical history. Early detection allows healthcare providers to recommend preventive strategies, lifestyle modifications, or medications such as anticoagulants to reduce clotting risk. Understanding your protein C resistance helps patients make informed decisions about long-term health, enables careful monitoring of clotting tendencies, and supports safe management strategies for individuals with a family or personal history of thrombotic events.
This panel assesses red blood cell count, hemoglobin, hematocrit, and iron levels to detect anemia. Blood is collected and analysed to determine the cause, which may include nutritional deficiency, blood loss, or chronic disease. Results guide supplementation, dietary recommendations, or additional testing. Understanding anemia status helps healthcare providers develop personalised treatment plans, improve oxygen delivery and energy levels, and prevent long-term complications. Patients benefit from early detection and management to maintain overall health and wellbeing.
This test measures Bence-Jones proteins in urine or blood, which can indicate abnormal plasma cell activity such as multiple myeloma. Blood or urine is collected and analysed to detect these proteins. Early detection helps healthcare providers diagnose plasma cell disorders, monitor disease progression, and guide treatment. Patients benefit from timely intervention, tailored therapy, and close monitoring to prevent organ damage and manage long-term outcomes effectively.
This test measures Bence-Jones proteins in urine or blood, which can indicate abnormal plasma cell activity such as multiple myeloma. Blood or urine is collected and analysed to detect these proteins. Early detection helps healthcare providers diagnose plasma cell disorders, monitor disease progression, and guide treatment. Patients benefit from timely intervention, tailored therapy, and close monitoring to prevent organ damage and manage long-term outcomes effectively.
This test determines your blood group, which is essential for safe transfusions, organ donation, and certain medical procedures. Blood is drawn, and laboratory analysis identifies ABO and Rh group. Knowing your blood type helps healthcare providers make safe transfusion decisions, plan surgical procedures, and provide critical care in emergencies. Patients also benefit from understanding their blood group for pregnancy planning, as Rh incompatibility can affect fetal health. This routine test is quick, reliable, and provides vital information for patient safety and overall medical management.
This test measures Factor VIII activity, a key protein in blood clotting. Blood is drawn and analysed to diagnose bleeding disorders such as hemophilia A or monitor treatment. Abnormal levels may cause excessive bleeding or clotting. Early detection allows healthcare providers to implement therapy, prevent complications, and provide ongoing management. Patients benefit by maintaining safe clotting function, receiving personalised treatment, and protecting long-term health.
This test evaluates a full blood count (FBC) with a five-part white cell differential. Blood is drawn and analysed to measure red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. Results help detect anemia, infections, inflammation, clotting disorders, or blood cancers. Early detection allows healthcare providers to implement appropriate treatments, monitor therapy, and prevent complications. Patients benefit by understanding their overall hematologic health, making informed decisions, and maintaining long-term wellness through proactive care and monitor
This test measures glucose-6-phosphate dehydrogenase (G6PD) activity, an enzyme critical for red blood cell function. Blood is collected and analysed to detect deficiency, which can cause hemolytic anemia in response to certain medications, foods, or infections. Early identification allows healthcare providers to provide guidance on avoiding triggers, monitoring blood health, and implementing preventive strategies. Patients benefit by reducing the risk of anemia, protecting overall health, and maintaining long-term red blood cell function.
This panel evaluates blood cells including red blood cells, white blood cells, and platelets. It helps identify anemia, infection, or blood disorders. Regular testing allows early detection of hematologic conditions and provides essential information for treatment planning. A simple blood draw is used, and results are interpreted in context with patient symptoms and other laboratory findings.
Measures hemoglobin levels, the protein in red blood cells responsible for carrying oxygen. Low levels may indicate anemia, fatigue, or nutritional deficiencies, while high levels may indicate dehydration or other health concerns. Regular monitoring helps maintain oxygen delivery to tissues and overall health. Blood is drawn via standard venipuncture, and results help guide dietary or medical interventions.
Identifies different types of hemoglobin in the blood, useful for diagnosing genetic disorders like sickle cell disease or thalassemia. This test helps determine inheritance patterns, guide patient management, and monitor treatment efficacy. A blood sample is required, and results are interpreted alongside complete blood counts and clinical history.
This test measures clotting parameters (Coagulation Profile 1) to evaluate how effectively blood forms clots. Blood is collected and analysed to detect bleeding disorders, monitor anticoagulant therapy, or assess risk of excessive clotting before procedures. Early detection allows healthcare providers to implement preventive measures, adjust medication, and manage potential complications. Patients benefit by gaining insight into blood clotting function, supporting safe healthcare decisions, and maintaining long-term vascular and overall health.
This test detects antibodies bound to red blood cells (Coombs or Direct Antiglobulin Test). Blood is collected and analysed to identify immune-mediated hemolytic anemia, transfusion reactions, or autoimmune conditions. Early detection allows healthcare providers to implement treatment strategies, monitor response, and prevent complications. Patients benefit from accurate diagnosis, tailored therapy, and long-term monitoring to maintain healthy blood counts and prevent organ damage.
This test measures D-dimers, fragments produced when blood clots are broken down. Blood is drawn and analysed to help detect conditions such as deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation. Elevated D-dimer levels can indicate active clotting, prompting further diagnostic imaging or intervention. Early detection allows healthcare providers to implement treatment, prevent complications, and monitor patient recovery. Patients benefit by understanding their clotting risk and receiving timely guidance for managing vascular health.
This test measures erythrocyte sedimentation rate (ESR), an indicator of inflammation in the body. Blood is drawn and analysed to detect conditions such as infection, autoimmune disease, or chronic inflammation. Elevated ESR guides healthcare providers in diagnosis, monitoring, and treatment planning. Patients benefit by detecting inflammatory conditions early, implementing preventive strategies, and supporting overall health and wellness.
This test measures haptoglobin, a protein that binds free hemoglobin in the blood, helping to protect kidneys and prevent oxidative damage. Blood is collected and analysed to detect hemolytic anemia or other conditions causing red blood cell breakdown. Low haptoglobin may indicate hemolysis, while elevated levels can reflect inflammation. Healthcare providers use results to diagnose underlying causes, monitor therapy, and guide interventions. Patients benefit from early detection of anemia, understanding their blood health, and taking steps to manage symptoms, prevent complications, and support overall wellness. Monitoring haptoglobin helps maintain red blood cell integrity and long-term hematologic hea
This test measures haptoglobin, a protein that binds free hemoglobin in the blood, helping to protect kidneys and prevent oxidative damage. Blood is collected and analysed to detect hemolytic anemia or other conditions causing red blood cell breakdown. Low haptoglobin may indicate hemolysis, while elevated levels can reflect inflammation. Healthcare providers use results to diagnose underlying causes, monitor therapy, and guide interventions. Patients benefit from early detection of anemia, understanding their blood health, and taking steps to manage symptoms, prevent complications, and support overall wellness. Monitoring haptoglobin helps maintain red blood cell integrity and long-term hematologic hea
This test measures protein C activity, an important factor in blood clot regulation. Blood is collected and analysed to assess the risk of thrombosis or clotting disorders. Abnormal levels may indicate deficiencies or increased risk of blood clots. Healthcare providers use results to guide anticoagulant therapy, lifestyle interventions, and monitoring. Patients benefit by understanding clotting risk, preventing complications such as deep vein thrombosis or stroke, and maintaining long-term vascular health. Early detection supports informed care and wellness.
This test measures protein electrophoresis, including immunoglobulin levels, to evaluate blood proteins and detect abnormal patterns. Blood is collected and analysed to identify conditions such as multiple myeloma, chronic inflammation, or immune disorders. Results help healthcare providers diagnose, monitor, and guide treatment. Patients benefit by understanding protein and immune status, identifying early disease, and implementing interventions to maintain health. Early detection enables proactive management, improving long-term wellness and quality of life.
This test measures prothrombin time, evaluating the blood’s ability to clot. Blood is collected and analysed to detect bleeding disorders, monitor anticoagulant therapy, or assess liver function. Abnormal clotting times may indicate risk of excessive bleeding or thrombosis. Healthcare providers use results to guide treatment, medication dosing, and preventive measures. Patients benefit by understanding clotting health, managing risks, and maintaining long-term cardiovascular and overall wellness. Timely assessment supports safe interventions and monitoring.
This test counts reticulocytes, immature red blood cells, providing insight into bone marrow function and red blood cell production. Blood is collected and analysed to evaluate anemia, recovery from blood loss, or bone marrow disorders. Results help healthcare providers monitor therapy, diagnose underlying conditions, and guide treatment. Patients benefit by understanding hematologic health, supporting red blood cell production, and maintaining overall wellness. Timely assessment enables proactive interventions and improved long-term outcomes.
This test measures serum free light chains, proteins produced by plasma cells that can indicate blood disorders such as multiple myeloma or other plasma cell dyscrasias. Blood is collected and analysed to detect abnormal patterns or levels. Early detection allows healthcare providers to monitor disease progression, guide treatment, and prevent complications. Patients benefit by identifying potential blood disorders early, receiving timely care, and supporting long-term health. Monitoring free light chains is critical for early intervention and proactive disease management.
This test screens for sickle cell disorders by detecting abnormal hemoglobin types in blood. Blood is collected and analysed to identify sickle cell trait or disease. Early detection allows healthcare providers to provide counseling, guide preventive care, and monitor for complications such as anemia, infections, or organ damage. Patients benefit by understanding genetic status, receiving timely interventions, and supporting long-term health. Screening promotes informed reproductive decisions, proactive management, and wellness.
This test measures thiopurine methyltransferase (TPMT) activity, an enzyme involved in metabolising certain medications. Blood is collected to evaluate genetic enzyme activity, guiding safe dosing of thiopurine drugs like azathioprine or 6-mercaptopurine. Abnormal activity may increase risk of toxicity or treatment failure. Healthcare providers use results to adjust medication safely, prevent side effects, and optimise therapy. Patients benefit by ensuring safe, effective treatment, minimising adverse effects, and maintaining long-term health. Timely assessment supports personalised care and proactive medication management.
This test measures plasma viscosity to assess blood flow characteristics, which can be altered in inflammation, infection, or hematologic disorders. Blood is collected and analysed to detect abnormal viscosity levels. Elevated or reduced values may indicate underlying disease, guiding healthcare providers in diagnosis and monitoring. Patients benefit by understanding vascular and systemic health, supporting timely intervention, and maintaining long-term wellness. Early detection allows proactive management and improved circulatory function.
